The vitamin D-antimicrobial peptide pathway and its role in protection against infection - PubMed (original) (raw)
Review
The vitamin D-antimicrobial peptide pathway and its role in protection against infection
Adrian F Gombart. Future Microbiol. 2009 Nov.
Abstract
Vitamin D deficiency has been correlated with increased rates of infection. Since the early 19th century, both environmental (i.e., sunlight) and dietary sources (cod liver) of vitamin D have been identified as treatments for TB. The recent discovery that vitamin D induces antimicrobial peptide gene expression explains, in part, the 'antibiotic' effect of vitamin D and has greatly renewed interest in the ability of vitamin D to improve immune function. Subsequent work indicates that this regulation is biologically important for the response of the innate immune system to wounds and infection and that deficiency may lead to suboptimal responses toward bacterial and viral infections. The regulation of the cathelicidin antimicrobial peptide gene is a human/primate-specific adaptation and is not conserved in other mammals. The capacity of the vitamin D receptor to act as a high-affinity receptor for vitamin D and a low-affinity receptor for secondary bile acids and potentially other novel nutritional compounds suggests that the evolutionary selection to place the cathelicidin gene under control of the vitamin D receptor allows for its regulation under both endocrine and xenobiotic response systems. Future studies in both humans and humanized mouse models will elucidate the importance of this regulation and lead to the development of potential therapeutic applications.
Figures
Figure 1. Photoproduction of vitamin D
In plants or fungi, sunlight or artificial UVB rays cleave ergosterol in the B-ring to produce ergocalciferol or vitamin D2. In a very similar reaction in skin, 7-dehydrocholesterol is cleaved to produce cholecalciferol or vitamin D3. Both forms can be used as sources of vitamin D.
Figure 2. Conversion of vitamin D2 or vitamin D3 into active vitamin D
Vitamin D2 or vitamin D3 are hydroxylated in the liver by the enzyme CYP27A1 into 25-hydroxyvitamin D. This form of vitamin D circulates in the blood and is used to determine the vitamin D status of individuals (deficient: ≤20 ng/ml; insufficient: 21–29 ng/ml; sufficient: ≥30 ng/ml). When required by the body, the 25-hydroxyvitamin D form is converted by the CYP27B1 enzyme into the bioactive form, 1,25-dihydroxyvitamin D, which binds to the vitamin D receptor and activates gene expression. This primarily occurs in the kidney, but also occurs locally in cells that express CYP27B1. Immune-activated macrophages produce significant amounts of CYP27B1 and 1,25-dihydroxyvitamin D.
Figure 3. Vitamin D-dependent Toll-like receptor-activation of cathelicidin gene expression
The current model proposes that when a pathogen is detected by its respective TLR, VDR and CYP27B1 gene expression are induced. This leads to 1-α-hydroxylation of 25(OH)D, which is taken up from the blood (in a complex with the D-binding protein) and subsequent binding of 1,25(OH)2D to the VDR. The cathelicidin gene is activated and the protein (hCAP18/LL-37) is synthesized for use against the pathogen that has been engulfed in the phagosome of the macrophage. TLR: Toll-like receptor; VDR: Vitamin D receptor.
Figure 4. A role for enteric receptors in regulating the innate immune system by inducing antimicrobial gene expression
Intestinal detoxification receptors and the VDR share ligands and target genes. It has been shown that primary bile acids are capable of inducing cathelicidin gene expression in biliary epithelial cells through the FXR. Secondary bile acids that are byproducts of metabolism of primary bile acids by intestinal bacteria induce the cathelicidin gene via the VDR. The extensive crosstalk by these receptors possibly creates a system where bile acids, xenobiotic compounds and microbial byproducts can maintain critical gut immunity by inducing antimicrobial gene expression. FXR: Farnesoid X receptor; VDR: Vitamin D receptor; RXR: Retinoid X receptor.
Similar articles
- Vitamin D and respiratory infection in adults.
Laaksi I. Laaksi I. Proc Nutr Soc. 2012 Feb;71(1):90-7. doi: 10.1017/S0029665111003351. Epub 2011 Nov 25. Proc Nutr Soc. 2012. PMID: 22115013 - Regulation of antimicrobial peptide gene expression by nutrients and by-products of microbial metabolism.
Campbell Y, Fantacone ML, Gombart AF. Campbell Y, et al. Eur J Nutr. 2012 Dec;51(8):899-907. doi: 10.1007/s00394-012-0415-4. Epub 2012 Jul 15. Eur J Nutr. 2012. PMID: 22797470 Free PMC article. Review. - Vitamin D, vitamin D receptor, and cathelicidin in the treatment of tuberculosis.
Selvaraj P. Selvaraj P. Vitam Horm. 2011;86:307-25. doi: 10.1016/B978-0-12-386960-9.00013-7. Vitam Horm. 2011. PMID: 21419277 Review. - Emerging Roles of Vitamin D-Induced Antimicrobial Peptides in Antiviral Innate Immunity.
White JH. White JH. Nutrients. 2022 Jan 11;14(2):284. doi: 10.3390/nu14020284. Nutrients. 2022. PMID: 35057465 Free PMC article. Review. - Vitamin D as an inducer of cathelicidin antimicrobial peptide expression: past, present and future.
White JH. White JH. J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):234-8. doi: 10.1016/j.jsbmb.2010.03.034. Epub 2010 Mar 17. J Steroid Biochem Mol Biol. 2010. PMID: 20302931 Review.
Cited by
- Immunomodulation in Non-traditional Therapies for Methicillin-resistant Staphylococcus aureus (MRSA) Management.
Subbarayudu S, Namasivayam SKR, Arockiaraj J. Subbarayudu S, et al. Curr Microbiol. 2024 Sep 6;81(10):346. doi: 10.1007/s00284-024-03875-7. Curr Microbiol. 2024. PMID: 39240286 Review. - Systemic Factors Effecting Human Beta-Defensins in Oral Cavity.
Atalay N, Balci N, Gürsoy M, Gürsoy UK. Atalay N, et al. Pathogens. 2024 Aug 2;13(8):654. doi: 10.3390/pathogens13080654. Pathogens. 2024. PMID: 39204254 Free PMC article. Review. - Transcriptomics analysis highlights potential ways in human pathogenesis in Leishmania braziliensis infected with the viral endosymbiont LRV1.
Felipin KP, Paloschi MV, Silva MDS, Ikenohuchi YJ, Santana HM, Setúbal SDS, Rego CMA, Lopes JA, Boeno CN, Serrath SN, De Medeiros EHRT, Pimentel IF, Oliveira AER, Cupolillo E, Cantanhêde LM, Ferreira RGM, Zuliani JP. Felipin KP, et al. PLoS Negl Trop Dis. 2024 May 14;18(5):e0012126. doi: 10.1371/journal.pntd.0012126. eCollection 2024 May. PLoS Negl Trop Dis. 2024. PMID: 38743668 Free PMC article. - A comprehensive review on pharmacologic agents, immunotherapies and supportive therapeutics for COVID-19.
Sharun K, Tiwari R, Yatoo MI, Natesan S, Megawati D, Singh KP, Michalak I, Dhama K. Sharun K, et al. Narra J. 2022 Dec;2(3):e92. doi: 10.52225/narra.v2i3.92. Epub 2022 Dec 8. Narra J. 2022. PMID: 38449903 Free PMC article. Review.
References
- Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am. J. Clin. Nutr. 2008;87(4):1080S–1086S. - PubMed
- Mangelsdorf DJ, Thummel C, Beato M, et al. The nuclear receptor superfamily: the second decade. Cell. 1995;83(6):835–839. ▪ Excellent review on nuclear receptors.
- Bouillon R, Garmyn M, Verstuyf A, Segaert S, Casteels K, Mathieu C. Paracrine role for calcitriol in the immune system and skin creates new therapeutic possibilities for vitamin D analogs. Eur. J. Endocrinol. 1995;133(1):7–16. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical